Cargando…
Development of predictive nomograms for clinical use to quantify the risk of isolating resistance prone organisms in patients with infected foot ulcers
Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus (MRSA) have been considered prevalent pathogens in foot infections. However, whether empiric therapy directed against these organisms is necessary, and in whom to consider treatment, is rather unclear. The aim of this study was t...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6518461/ https://www.ncbi.nlm.nih.gov/pubmed/31063087 http://dx.doi.org/10.1017/S0950268818003667 |
_version_ | 1783418453918482432 |
---|---|
author | Farkas, A. Lin, F. Bui, K. Liu, F. An, G. L. Pakholskiy, A. Stavropoulos, C. F. Lantis, J. C. Yassin, A. |
author_facet | Farkas, A. Lin, F. Bui, K. Liu, F. An, G. L. Pakholskiy, A. Stavropoulos, C. F. Lantis, J. C. Yassin, A. |
author_sort | Farkas, A. |
collection | PubMed |
description | Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus (MRSA) have been considered prevalent pathogens in foot infections. However, whether empiric therapy directed against these organisms is necessary, and in whom to consider treatment, is rather unclear. The aim of this study was to develop predictive algorithms for forecasting the probability of isolating these organisms in the infected wounds of patients in a population where the prevalence of resistant pathogens is low. This was a retrospective study of regression model-based risk factor analysis that included 140 patients who presented with infected, culture positive foot ulcers to two urban hospitals. A total of 307 bacteria were identified, most frequently MRSA (11.1%). P. aeruginosa prevalence was 6.5%. In the multivariable analysis, amputation (odds ratio (OR) 5.75, 95% confidence interval (CI) 1.48–27.63), renal disease (OR 5.46, 95% CI 1.43–25.16) and gangrene (OR 2.78, 95% CI 0.82–9.59) were identified as risk factors associated with higher while diabetes (OR 0.07, 95% CI 0.01–0.34) and Infectious Diseases Society of America infection severity >3 (OR 0.18, 95% CI 0.03–0.65) were associated with lower odds of P. aeruginosa isolation (C statistic 0.81). Similar analysis for MRSA showed that amputation was associated with significantly lower (OR 0.29, 95% CI 0.09–0.79) risk, while history of MRSA infection (OR 5.63, 95% CI 1.56–20.63) and osteomyelitis (OR 2.523, 95% CI 1.00–6.79) was associated with higher odds of isolation (C statistic 0.69). We developed two predictive nomograms with reasonable to strong ability to discriminate between patients who were likely of being infected with P. aeruginosa or MRSA and those who were not. These analyses confirm the association of some, but also question the significance of other frequently described risk factors in predicting the isolation of these organisms. |
format | Online Article Text |
id | pubmed-6518461 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Cambridge University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-65184612019-06-04 Development of predictive nomograms for clinical use to quantify the risk of isolating resistance prone organisms in patients with infected foot ulcers Farkas, A. Lin, F. Bui, K. Liu, F. An, G. L. Pakholskiy, A. Stavropoulos, C. F. Lantis, J. C. Yassin, A. Epidemiol Infect Original Paper Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus (MRSA) have been considered prevalent pathogens in foot infections. However, whether empiric therapy directed against these organisms is necessary, and in whom to consider treatment, is rather unclear. The aim of this study was to develop predictive algorithms for forecasting the probability of isolating these organisms in the infected wounds of patients in a population where the prevalence of resistant pathogens is low. This was a retrospective study of regression model-based risk factor analysis that included 140 patients who presented with infected, culture positive foot ulcers to two urban hospitals. A total of 307 bacteria were identified, most frequently MRSA (11.1%). P. aeruginosa prevalence was 6.5%. In the multivariable analysis, amputation (odds ratio (OR) 5.75, 95% confidence interval (CI) 1.48–27.63), renal disease (OR 5.46, 95% CI 1.43–25.16) and gangrene (OR 2.78, 95% CI 0.82–9.59) were identified as risk factors associated with higher while diabetes (OR 0.07, 95% CI 0.01–0.34) and Infectious Diseases Society of America infection severity >3 (OR 0.18, 95% CI 0.03–0.65) were associated with lower odds of P. aeruginosa isolation (C statistic 0.81). Similar analysis for MRSA showed that amputation was associated with significantly lower (OR 0.29, 95% CI 0.09–0.79) risk, while history of MRSA infection (OR 5.63, 95% CI 1.56–20.63) and osteomyelitis (OR 2.523, 95% CI 1.00–6.79) was associated with higher odds of isolation (C statistic 0.69). We developed two predictive nomograms with reasonable to strong ability to discriminate between patients who were likely of being infected with P. aeruginosa or MRSA and those who were not. These analyses confirm the association of some, but also question the significance of other frequently described risk factors in predicting the isolation of these organisms. Cambridge University Press 2019-03-20 /pmc/articles/PMC6518461/ /pubmed/31063087 http://dx.doi.org/10.1017/S0950268818003667 Text en © The Author(s) 2019 http://creativecommons.org/licenses/by/4.0/ This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Paper Farkas, A. Lin, F. Bui, K. Liu, F. An, G. L. Pakholskiy, A. Stavropoulos, C. F. Lantis, J. C. Yassin, A. Development of predictive nomograms for clinical use to quantify the risk of isolating resistance prone organisms in patients with infected foot ulcers |
title | Development of predictive nomograms for clinical use to quantify the risk of isolating resistance prone organisms in patients with infected foot ulcers |
title_full | Development of predictive nomograms for clinical use to quantify the risk of isolating resistance prone organisms in patients with infected foot ulcers |
title_fullStr | Development of predictive nomograms for clinical use to quantify the risk of isolating resistance prone organisms in patients with infected foot ulcers |
title_full_unstemmed | Development of predictive nomograms for clinical use to quantify the risk of isolating resistance prone organisms in patients with infected foot ulcers |
title_short | Development of predictive nomograms for clinical use to quantify the risk of isolating resistance prone organisms in patients with infected foot ulcers |
title_sort | development of predictive nomograms for clinical use to quantify the risk of isolating resistance prone organisms in patients with infected foot ulcers |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6518461/ https://www.ncbi.nlm.nih.gov/pubmed/31063087 http://dx.doi.org/10.1017/S0950268818003667 |
work_keys_str_mv | AT farkasa developmentofpredictivenomogramsforclinicalusetoquantifytheriskofisolatingresistanceproneorganismsinpatientswithinfectedfootulcers AT linf developmentofpredictivenomogramsforclinicalusetoquantifytheriskofisolatingresistanceproneorganismsinpatientswithinfectedfootulcers AT buik developmentofpredictivenomogramsforclinicalusetoquantifytheriskofisolatingresistanceproneorganismsinpatientswithinfectedfootulcers AT liuf developmentofpredictivenomogramsforclinicalusetoquantifytheriskofisolatingresistanceproneorganismsinpatientswithinfectedfootulcers AT angl developmentofpredictivenomogramsforclinicalusetoquantifytheriskofisolatingresistanceproneorganismsinpatientswithinfectedfootulcers AT pakholskiya developmentofpredictivenomogramsforclinicalusetoquantifytheriskofisolatingresistanceproneorganismsinpatientswithinfectedfootulcers AT stavropouloscf developmentofpredictivenomogramsforclinicalusetoquantifytheriskofisolatingresistanceproneorganismsinpatientswithinfectedfootulcers AT lantisjc developmentofpredictivenomogramsforclinicalusetoquantifytheriskofisolatingresistanceproneorganismsinpatientswithinfectedfootulcers AT yassina developmentofpredictivenomogramsforclinicalusetoquantifytheriskofisolatingresistanceproneorganismsinpatientswithinfectedfootulcers |